Summary

The promise of new-generation polymer, metallic, drug-eluting stents (DES) and biodegradable vascular scaffolds (BVS) are tantalizing, yet the question of whether they produce meaningful differences in vascular responses remains to be determined. This article discusses the development of DES with various polymers, as well as the early and late clinical advantages of bioabsorbable polymer DES.